Results 41 to 50 of about 107,286 (246)

Novel pathways of heart failure with preserved ejection fraction [PDF]

open access: yes, 2016
INTRODUCTION: Diastolic heart failure (HF) i.e., HF with preserved ejection fraction (HFpEF) accounts for ~50% of all clinical HF presentations; but unlike systolic HF i.e., HF with reduced ejection fraction (HFrEF), there are no evidenced based ...
Li, Shanpeng
core   +2 more sources

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes

open access: yesBiomolecules, 2020
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti   +14 more
doaj   +1 more source

Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. [PDF]

open access: yes, 2015
BACKGROUND: Nitrates are commonly prescribed to enhance activity tolerance in patients with heart failure and a preserved ejection fraction. We compared the effect of isosorbide mononitrate or placebo on daily activity in such patients.
Anstrom, Kevin J.   +18 more
core   +2 more sources

Role of global longitudinal strain in assessment of left ventricular systolic function in patients with heart failure with preserved ejection fraction

open access: yesJournal of the Saudi Heart Association, 2019
Objectives: To detect systolic dysfunction in heart failure with preserved ejection fraction (HFpEF) patients by using global longitudinal strain (GLS).
Hasanain Ali Hameed Bshiebish   +2 more
doaj   +1 more source

Clinical utility of exercise training in heart failure with reduced and preserved ejection fraction [PDF]

open access: yes, 2015
Reduced exercise tolerance is an independent predictor of hospital readmission and mortality in patients with heart failure (HF). Exercise training for HF patients is well established as an adjunct therapy, and there is sufficient evidence to support the
Goh, CY   +4 more
core   +2 more sources

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction [PDF]

open access: yes, 2019
Aims: Impaired left ventricular diastolic function leading to elevated left atrial pressures, particularly during exertion, is a key driver of symptoms and outcomes in heart failure with preserved ejection fraction (HFpEF). Insertion of an interatrial
Aytug, H   +22 more
core   +2 more sources

Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study. [PDF]

open access: yes, 2017
BackgroundApproximately half of the patients presenting with new-onset heart failure (HF) have HF with preserved left ventricular ejection fraction (HFpEF) and HF with mid-range left ventricular ejection fraction (HFmrEF).
Amurthur, Badri   +8 more
core   +1 more source

The Prognostic Role of the Left Atrium in Hypertensive Patients with HFpEF: Does Function Matter More than Structure?

open access: yesLife
Background: In arterial hypertension (AH), adverse hemodynamic consequences in the left atrium (LA) are often observed. The prognostic significance of functional vs.
Artem Ovchinnikov   +6 more
doaj   +1 more source

Anaemia, iron deficiency and heart failure in 2020: facts and numbers

open access: yesESC Heart Failure, 2020
Anaemia is defined by WHO as Hb 
Vijay K. Chopra, Stefan D. Anker
doaj   +1 more source

‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure [PDF]

open access: yes, 2015
The clinical syndrome of heart failure is one of the leading causes of hospitalisation and mortality in older adults. An association between cognitive impairment and heart failure is well described but our understanding of the relationship between the ...
Cannon, Jane A.   +2 more
core   +4 more sources

Home - About - Disclaimer - Privacy